2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 22,800.00
... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...
April 2012
1200 pages
2012 Global Agrochemical Companies Product Portfolio Analyses
US$ 1,480.00
For each company, the analyses present: Extensive review of the major product lines. Applications, advantages and weaknesses of leading products. The companies analyzed in the report: Arysta, BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 75 pages.
April 2012
75 pages
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
570 pages
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 5,360.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2012
590 pages
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
565 pages
2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
620 pages
The 2012 Leading Agrochemical Companies Financial Analyses
US$ 1,480.00
Each company’s analysis provides: Sales and operating profit by division, product line, and geographic region. Five-year sales and profit performance. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 85 pages and 65 tables
March 2012
85 pages
The 2012 Leading Agrochemical Companies R&D Expenditures and Major Programs
US$ 1,320.00
For each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 38 pages
March 2012
38 pages
The 2012 Leading Agrochemical Companies Collaborative Arrangements
US$ 1,200.00
... : Major joint ventures, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 56 pages
March 2012
56 pages
The 2012 Top Ten World's Leading Chemical Companies
US$ 11,600.00
... include: To establish comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading chemical companies. To help current suppliers realistically assess their technological and marketing capabilities vis-a-vis leading competitors. To ...
March 2012
600 pages
The 2012 French Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the French coagulation market, including: Major issues pertaining to the French coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
405 pages
The 2012 German Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the German coagulation market, including: Major issues pertaining to the German coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
406 pages
The 2012 Italian Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the Italian coagulation market, including: Major issues pertaining to the Italian coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
402 pages
The 2012 Japanese Coagulation Market
US$ 5,200.00
This report presents a comprehensive analysis of the Japanese coagulation market, including: Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
March 2012
402 pages
The 2012 Spanish Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the Spanish coagulation market, including: Major issues pertaining to the Spanish coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
398 pages
The 2012 UK Coagulation Market
US$ 4,320.00
This report presents a comprehensive analysis of the UK coagulation market, including: Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...
March 2012
409 pages
The 2012 US Coagulation Market
US$ 6,800.00
This report presents a comprehensive analysis of the US coagulation market, including: Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...
March 2012
424 pages
The 2012 Top Ten World's Leading Diagnostic Imaging Companies
US$ 10,000.00
... establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis ...
March 2012
850 pages
The 2012 Leading Diagnostic Imaging Companies Strategic Directions
US$ 2,000.00
For each company, the report provides insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu ...
March 2012
41 pages
The 2012 Leading Diagnostic Imaging Companies Marketing Tactics
US$ 2,000.00
For each company, the analysis presents: The U.S. and international sales force size in major geographic regions. Selling options, including rental plans, leasing and others. Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc. System ...
March 2012
50 pages
The 2012 Leading Diagnostic Imaging Companies Comparative Analysis
US$ 680.00
This report ranks the world’s major diagnostic imaging companies according to the following criteria: Sales and market shares in the U.S., Europe, Japan and other geographic regions. Sales by modality. Operating profit and margins. R&D expenditures. The ...
March 2012
5 pages
The 2012 Leading Diagnostic Imaging Companies Collaborations
US$ 1,480.00
For each company, the report analyzes: Major joint venture, distribution, O.E.M., and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, ...
March 2012
82 pages
The 2012 Leading Diagnostic Imaging Companies Financial Analyses
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
March 2012
92 pages
The 2012 Leading Diagnostic Imaging Companies Organizations and Management
US$ 1,480.00
... and strategies. Recent acquisitions, divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...
March 2012
92 pages
The 2012 Leading Diagnostic Imaging Companies R&D Expenditures and Major Programs
US$ 1,480.00
For each company, the report provides: R&D budget, research facilities, and staff. New technologies, systems, and applications in development, including their specifications and anticipated introduction dates. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, ...
March 2012
40 pages
The 2012 Leading Diagnostic Imaging Companies Technological Know-How
US$ 1,480.00
For each company, the report analyzes: Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens ...
March 2012
60 pages
The 2012 Leading Diagnostic Imaging Companies Product Portfolio Analyses
US$ 1,480.00
For each company, the analyses present: Placements and installed base of major systems in the U.S. and abroad, by modality. Review of major product lines. Specifications, features, advantages, weaknesses, introduction dates and prices of current systems. The companies analyzed in the report: Aloka, ...
March 2012
230 pages
The 2012 Leading Diagnostics Imaging Companies Facilities and Employees
US$ 1,480.00
For each company, the analyses present: Location and size of administrative, manufacturing, and R&D facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...
March 2012
32 pages
The 2012 Top 10 World’s Leading Flavor and Fragrance Companies
US$ 11,360.00
... To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading flavor and fragrance companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a- ...
March 2012
550 pages
The 2012 Leading Flavor and Fragrance Companies Financial Analyses
US$ 1,960.00
For each company, the analysis provides: Sales estimates by product category and geographic region. Five-year sales and operating profit performance. The companies analyzed in the report: Firmenich, Frutarom, Givaudan, T. Hasegawa, IFF, Mane, Robertet, Sensient, Symrise, and Takasago. Contains 65 pages ...
March 2012
65 pages
The 2012 Leading Flavor and Fragrance Companies Major Facilities and Employees
US$ 1,480.00
For each company, the report provides: Production, compounding, creative, and R&D facilities by country. Workforce size. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and Takasago. Contains 52 pages
March 2012
52 pages
The 2012 Leading Flavor and Fragrance Companies Product Portfolios and Technological Know-How
US$ 1,480.00
For each company, the report analyzes: Major products and services, including fragrances (fine, technical), flavors, aroma chemicals (high-volume standard products, high-volume specialties, low-volume specialties), essential oils, and others. Know-how in chemical technology, biotechnology, aromacology and ...
March 2012
80 pages
The 2012 Leading Flavor and Fragrance Companies Marketing Capabilities
US$ 1,480.00
For each company, the analysis presents: Sales force in the U.S. and other international markets. Major sale office locations. Distribution strategies. Major promotional tactics. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and ...
March 2012
20 pages
